Clinical Trial Update: A Study of the Efficacy of Prolonged-Release Melatonin Versus Placebo in Diabetic Patients Suffering From Insomnia [Phase 2]

View source ↗

Summary

A Phase 2 trial comparing prolonged-release melatonin with placebo in adults with type 2 diabetes and insomnia; results have been completed and posted (2009).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Insomnia
• Type 2 Diabetes Mellitus

Drugs mentioned

• Prolonged-Release Melatonin (melatonin)

Snippet

Sponsor: Neurim Pharmaceuticals Ltd. | Conditions: Diabetes Mellitus, Type 2, Insomnia | Phase 2 | Status: COMPLETED | Results posted: 2009-03-25